Preparation of new doxycycline monohydrate polymorphs by ultrasonication enhanced supercritical antisolvent recrystallization process
Year: 2025
Type: article
Abstract: Polymorphism is a crucial factor in the pharmaceutical industry, as different polymorphs can display different physicochemical properties, including stability, solubility, and/or bioavailability. The ultrasonication-enhanced supercritical antisolvent recrystallization (UE-SAR) process is a novel investigated approach for producing novel polymorphs.This work aimed to generate and characterize doxycycline monohydrate (DOXY·H 2 O forms II, III, and IV) polymorphs produced from suspensions of its as received form (DOXY·H 2 O form I) using the UE-SAR process. A two-stage Design of Experiments (DoE) analysis was performed to assess the impact of various processing parameters such as ultrasonication, pressure, temperature, and residence time on the polymorphic outcome in each experimental run. The solid state characterization revealed that the produced polymorphs (DOXY·H 2 O form II, DOXY·H 2 O form III) have distinct powder X-ray diffraction (PXRD), Raman, Fourier Transform Infrared (FTIR) patterns and higher thermal stability. Moreover, the structures of DOXY·H 2 O forms I and II were further elucidated by solid state nuclear magnetic resonance (SS NMR) from 13 C and 15 N cross polarization (CP) and magic angle spinning (MAS) spectra. Overall, the results from this work highlight that use US-SAR method can induce the formation of different supramolecular structures in tetracyclines when they are suspended in a supercritical phase, and polymorphic purity can be enhanced by prolonged ultrasonication. • The supercritical antisolvent recrystallization (SAR) process was developed as an effective platform to generate novel polymorphs of DOXY·H 2 O. • Two-stage DoE was applied to obtain PXRD-pure polymorphs by the ultrasonication enhanced (UE)-SAR process. • Purity of the polymorphs was achieved after prolonged ultrasonication. • Distinct PXRD, Raman, DSC, and FTIR patterns validated DOXY·H 2 O polymorphs. • The structures of DOXY·H 2 O forms I and II were elucidated using SS NMR.
Source: Journal of CO2 Utilization
Language: English
Subfield: Materials Chemistry
Field: Materials Science
Domain: Physical Sciences
Open Access status: gold
Estimated APC paid: $3,360
Awards: G1628197152, Controlled Nucleation for the Continuous Crystallization of Nanopharmaceuticals, Do desenvolvimento de novos produtos bioactivos à descoberta de novos materiais funcionais: uma abordagem estrutural em áreas emergentes, G592507449, SSPC_Phase 2, Long Acting Medicines for Complex Therapeutics Needed Now
OpenAlex ID: W4409911636
